On the other hand, the Oncotype Dx signature exhibited nearly the same correlation pattern in all TCGA breast cancer patients and luminal A-type breast cancer patients (Figures 8D, E) as in the cohort of ER+/HER2- breast cancer patients (Figure 7D). This evidence concerns the gene ERBB2 and breast carcinoma.